These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29175359)

  • 1. Trial Duration and Risk Reduction in Combination Therapy Trials for Pulmonary Arterial Hypertension: A Systematic Review.
    Lajoie AC; Guay CA; Lega JC; Lauzière G; Simard S; Lambert C; Lacasse Y; Bonnet S; Provencher S
    Chest; 2018 May; 153(5):1142-1152. PubMed ID: 29175359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of monotherapy versus combination therapy for pulmonary arterial hypertension.
    Fox BD; Shimony A; Langleben D
    Am J Cardiol; 2011 Oct; 108(8):1177-82. PubMed ID: 21864815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy versus monotherapy for pulmonary arterial hypertension: a meta-analysis.
    Lajoie AC; Lauzière G; Lega JC; Lacasse Y; Martin S; Simard S; Bonnet S; Provencher S
    Lancet Respir Med; 2016 Apr; 4(4):291-305. PubMed ID: 26935844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination Therapy for Pulmonary Arterial Hypertension: A Systematic Review and Meta-analysis.
    Fox BD; Shtraichman O; Langleben D; Shimony A; Kramer MR
    Can J Cardiol; 2016 Dec; 32(12):1520-1530. PubMed ID: 27378592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Clinical Worsening End Points as a Surrogate for Mortality in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Tremblay É; Gosselin C; Mai V; Lajoie AC; Kilo R; Weatherald J; Lacasse Y; Bonnet S; Lega JC; Provencher S
    Circulation; 2022 Aug; 146(8):597-612. PubMed ID: 35862151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.
    Shah SS; Ohlsson A; Halliday H; Shah VS
    Cochrane Database Syst Rev; 2003; (1):CD002058. PubMed ID: 12535425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimum duration of regimens for Helicobacter pylori eradication.
    Yuan Y; Ford AC; Khan KJ; Gisbert JP; Forman D; Leontiadis GI; Tse F; Calvet X; Fallone C; Fischbach L; Oderda G; Bazzoli F; Moayyedi P
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008337. PubMed ID: 24338763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review of infrapopliteal drug-eluting stents: a meta-analysis of randomized controlled trials.
    Katsanos K; Spiliopoulos S; Diamantopoulos A; Karnabatidis D; Sabharwal T; Siablis D
    Cardiovasc Intervent Radiol; 2013 Jun; 36(3):645-58. PubMed ID: 23435741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between the efficacy of combination therapy and monotherapy in connective tissue disease associated pulmonary arterial hypertension: a systematic review and meta-analysis.
    Pan J; Lei L; Zhao C
    Clin Exp Rheumatol; 2018; 36(6):1095-1102. PubMed ID: 29998831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of sequential combination therapy for pulmonary arterial hypertension: A meta-analysis of Randomized-Controlled Trials.
    Tan Z; Wu PY; Zhu TT; Su W; Fang ZF
    Pulm Pharmacol Ther; 2022 Oct; 76():102144. PubMed ID: 35918025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Pulmonary Arterial Hypertension-specific Therapy in Pulmonary Arterial Hypertension: A Meta-analysis of Randomized Controlled Trials.
    Liu HL; Chen XY; Li JR; Su SW; Ding T; Shi CX; Jiang YF; Zhu ZN
    Chest; 2016 Aug; 150(2):353-66. PubMed ID: 27048870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy in pulmonary arterial hypertension: a meta-analysis.
    Bai Y; Sun L; Hu S; Wei Y
    Cardiology; 2011; 120(3):157-65. PubMed ID: 22212696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants.
    Shah SS; Ohlsson A; Halliday H; Shah VS
    Cochrane Database Syst Rev; 2003; (2):CD002057. PubMed ID: 12804423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah S
    Cochrane Database Syst Rev; 2003; (2):CD003481. PubMed ID: 12804469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence-based pharmacologic management of pulmonary arterial hypertension.
    Benedict N; Seybert A; Mathier MA
    Clin Ther; 2007 Oct; 29(10):2134-53. PubMed ID: 18042471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chondroitin for osteoarthritis.
    Singh JA; Noorbaloochi S; MacDonald R; Maxwell LJ
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD005614. PubMed ID: 25629804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trial designs in PAH: shifting from functional measurements to long-term clinical outcomes.
    Studer SM; Gilkin RJ
    Am J Manag Care; 2014 Mar; 20(6 Suppl):S115-22. PubMed ID: 24716456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogen-reduced platelets for the prevention of bleeding.
    Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.